EDGAR Filing Documents for 0001415889-13-001485

Form 8-K - Current report:

SEC Accession No. 0001415889-13-001485

Filing Date

2013-08-02

Accepted

2013-08-02 16:10:57

Documents

Period of Report

2013-07-30

Items

Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1		vista8k_aug12013.htm	8-K	26420
2	SENIOR SECURED CONVERTIBLE PROMISSORY NOTE	note.htm	EX-10.1	232981
3	WARRANT	warrant.htm	EX-10.2	162840
	Complete submission text file	0001415889-13-001485.txt		423587

Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080

Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-244-9990

VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)